Gujarat Terce Laboratories Limited
Bombay Stock ExchangeTotal Valuation
Gujarat Terce Laboratories Limited carries a market capitalization of 264.83M, placing it among publicly traded companies globally. Its enterprise value stands at 206.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 264.83M |
| Enterprise Value | 206.17M |
Share Statistics
Gujarat Terce Laboratories Limited currently has 7.79M shares outstanding.
| Shares Outstanding | 7.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Gujarat Terce Laboratories Limited trades at a trailing price-to-earnings ratio of 10.59. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 3.02.
| PE Ratio | 10.59 |
| PS Ratio | 0.50 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Gujarat Terce Laboratories Limited trades at an EV/EBITDA multiple of 6.20 and an EV/FCF ratio of 157.40. The EV/Sales ratio of 0.43 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.43 |
| EV / EBITDA | 6.20 |
| EV / EBIT | 6.20 |
| EV / FCF | 157.40 |
Financial Position
Gujarat Terce Laboratories Limited maintains a current ratio of 1.32, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.33, indicating elevated leverage, while an interest coverage ratio of 18.53 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.32 |
| Quick Ratio | 0.38 |
| Debt / Equity | 13.33 |
| Debt / EBITDA | 0.39 |
| Interest Coverage | 18.53 |
Financial Efficiency
Gujarat Terce Laboratories Limited posts a return on equity of 37.03 and a return on invested capital of 26.20.
| Return on Equity (ROE) | 37.03 |
| Return on Assets (ROA) | 9.38 |
| Return on Invested Capital (ROIC) | 26.20 |
| Return on Capital Employed (ROCE) | 33.05 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.61 |
Taxes
Over the trailing twelve months, Gujarat Terce Laboratories Limited has paid 8.23M in income taxes, reflecting an effective tax rate of 27.03.
| Income Tax | 8.23M |
| Effective Tax Rate | 27.03 |
Stock Price Statistics
Gujarat Terce Laboratories Limited's stock has declined approximately -32.65306% over the past 52 weeks. The 50-day moving average sits at 35.27, while the 200-day moving average is 40.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | -32.65306% |
| 50-Day Moving Average | 35.27 |
| 200-Day Moving Average | 40.92 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Gujarat Terce Laboratories Limited generated 474.73M in revenue and converted that into 22.22M in net income, yielding earnings per share of 2.88. EBITDA reached 33.25M, while operating income came in at 33.25M.
| Revenue | 474.73M |
| Gross Profit | 303.39M |
| Operating Income | 33.25M |
| Pretax Income | 30.45M |
| Net Income | 22.22M |
| EBITDA | 33.25M |
| EBIT | 33.25M |
| Earnings Per Share (EPS) | 2.88 |
Balance Sheet
Gujarat Terce Laboratories Limited holds 42.08M in cash and equivalents against 12.96M in total debt, resulting in a net debt position of -15.63M. Total book value stands at 77.91M, with working capital of 34.63M providing operational flexibility.
| Cash & Cash Equivalents | 42.08M |
| Total Debt | 12.96M |
| Net Debt | -15.63M |
| Equity (Book Value) | 77.91M |
| Book Value Per Share | 10.23 |
| Working Capital | 34.63M |
Margins
Gujarat Terce Laboratories Limited operates with a gross margin of 63.91, reflecting its pricing power and cost economics. The operating margin of 7.00 and net profit margin of 4.68 provide insight into operational efficiency.
| Gross Margin | 63.91 |
| Operating Margin | 7.00 |
| Pretax Margin | 6.41 |
| Profit Margin | 4.68 |
| EBITDA Margin | 7.00 |
Scores
Gujarat Terce Laboratories Limited posts an Altman Z-Score of 3.50, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.50 |